Compare GFS & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFS | A |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.8B | 38.0B |
| IPO Year | 2017 | 1999 |
| Metric | GFS | A |
|---|---|---|
| Price | $40.58 | $178.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 22 |
| Target Price | $64.77 | ★ $182.05 |
| AVG Volume (30 Days) | ★ 6.0M | 1.6M |
| Earning Date | 11-04-2026 | 11-23-2026 |
| Dividend Yield | ★ 1.19% | 0.57% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 3.55 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $7.83 | $7.94 |
| Revenue Next Year | $13.27 | $6.42 |
| P/E Ratio | ★ $29.28 | $50.68 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $32.02 | $108.35 |
| 52 Week High | $92.55 | $182.99 |
| Indicator | GFS | A |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 56.66 |
| Support Level | N/A | $169.59 |
| Resistance Level | $50.09 | $182.99 |
| Average True Range (ATR) | 2.13 | 5.29 |
| MACD | -0.48 | -0.38 |
| Stochastic Oscillator | 41.42 | 65.19 |
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.